Olivo Alicia C, EVP, GC and Business Development at NeoGenomics Inc. ($NEO), sold shares on the open market twice in the last year, totaling about $300 thousand. Her most recent sale occurred on November 25, 2025. These sales rank her 7,555th among 11,678 insiders by volume, well below the average of $8.6 million per seller across 6.37 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | A | Restricted Stock Unit | 89013 | $0.00 | 205,500.0000 | 129,812,211 | 76.41% | 0.07% |
| March 1, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | A | Stock Option (Right to Buy) | 147804 | $0.00 | 297,598.0000 | 129,812,211 | 98.67% | 0.11% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 8295 | $0.00 | 88,104.0000 | 129,812,211 | 8.60% | 0.01% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 8443 | $0.00 | 96,547.0000 | 129,812,211 | 9.58% | 0.01% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 3323 | $0.00 | 93,224.0000 | 129,812,211 | 3.44% | 0.00% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Restricted Stock Unit | 21079 | $0.00 | 108,044.0000 | 129,812,211 | 16.32% | 0.02% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Restricted Stock Unit | 8443 | $0.00 | 74,328.0000 | 129,812,211 | 10.20% | 0.01% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 21079 | $0.00 | 96,399.0000 | 129,812,211 | 27.99% | 0.02% |
| Jan. 13, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 59382 | $0.00 | 90,465.0000 | 129,387,801 | 191.04% | 0.05% |
| Jan. 13, 2026 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 15145 | $0.00 | 75,320.0000 | 129,387,801 | 16.74% | 0.01% |
| Nov. 25, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Stock Option (Right to Buy) | 8977 | $0.00 | 108,788.0000 | 129,387,801 | 7.62% | 0.01% |
| Nov. 25, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | S | Common Stock | 20916 | $12.00 | 31,083.0000 | 129,387,801 | 40.22% | 0.02% |
| Nov. 25, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 8977 | $10.05 | 51,999.0000 | 129,387,801 | 20.87% | 0.01% |
| Oct. 16, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | S | Common Stock | 4918 | $10.00 | 43,022.0000 | 128,461,383 | 10.26% | 0.00% |
| Sept. 1, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 1666 | $0.00 | 47,940.0000 | 128,461,383 | 3.36% | 0.00% |
| Aug. 1, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 14 | $0.00 | 49,606.0000 | 128,461,383 | 0.03% | 0.00% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Restricted Stock Unit | 6503 | $0.00 | 146,009.0000 | 128,461,383 | 4.26% | 0.01% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 1584 | $0.00 | 49,620.0000 | 128,461,383 | 3.09% | 0.00% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 6503 | $0.00 | 51,204.0000 | 128,461,383 | 14.55% | 0.01% |
| May 1, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 652 | $0.00 | 44,701.0000 | 128,461,383 | 1.44% | 0.00% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Common Stock | 8443 | $0.00 | 47,857.0000 | 128,461,383 | 21.42% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | F | Common Stock | 2504 | $0.00 | 45,353.0000 | 128,461,383 | 5.23% | 0.00% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | A | Stock Option (Right to Buy) | 107450 | $0.00 | 149,794.0000 | 128,461,383 | 253.76% | 0.08% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | A | Restricted Stock Unit | 63238 | $0.00 | 135,626.0000 | 128,461,383 | 87.36% | 0.05% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | M | Restricted Stock Unit | 8443 | $0.00 | 89,274.0000 | 128,461,383 | 8.64% | 0.01% |
| Jan. 14, 2025 | NEOGENOMICS INC | $NEO | Olivo Alicia C | EVP, GC & Business Development | A | Restricted Stock Unit | 59382 | $0.00 | 97,717.0000 | 0 | 154.90% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | M | Restricted Stock Unit | 6502 | $0.00 | 13,006.0000 | 0 | 33.33% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | F | Common Stock | 1584 | $14.86 | 39,414.0000 | 0 | 3.86% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | M | Common Stock | 6502 | $0.00 | 40,998.0000 | 0 | 18.85% | 0.00% |
| Nov. 15, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | S | Common Stock | 5175 | $15.36 | 37,129.0000 | 0 | 12.23% | 0.00% |
| Sept. 1, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | F | Common Stock | 1666 | $0.00 | 42,147.0000 | 0 | 3.80% | 0.00% |
| Aug. 15, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | S | Common Stock | 1040 | $16.05 | 43,813.0000 | 0 | 2.32% | 0.00% |
| Aug. 1, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | F | Common Stock | 14 | $0.00 | 44,853.0000 | 0 | 0.03% | 0.00% |
| May 15, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | S | Common Stock | 1049 | $15.74 | 44,867.0000 | 0 | 2.28% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | M | Restricted Stock Unit | 6502 | $0.00 | 38,335.0000 | 0 | 14.50% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | M | Common Stock | 6502 | $0.00 | 40,998.0000 | 0 | 18.85% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | F | Common Stock | 1584 | $14.86 | 39,414.0000 | 0 | 3.86% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | M | Common Stock | 6502 | $0.00 | 45,916.0000 | 0 | 16.50% | 0.00% |
| May 1, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | F | Common Stock | 652 | $0.00 | 34,496.0000 | 0 | 1.86% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | A | Performance Stock Unit | 25330 | $0.00 | 44,838.0000 | 0 | 129.84% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | A | Stock Option (Right to Buy) | 42344 | $0.00 | 42,344.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | A | Restricted Stock Unit | 25329 | $0.00 | 44,837.0000 | 0 | 129.84% | 0.00% |
| Feb. 15, 2024 | NEOGENOMICS INC | $NEO | Olivo Alicia C | General Counsel | S | Common Stock | 2587 | $14.96 | 34,866.0000 | 0 | 6.91% | 0.00% |